82_FR_123 82 FR 122 - Federal Management Regulations; Transportation Prepayment Audit Requirements

82 FR 122 - Federal Management Regulations; Transportation Prepayment Audit Requirements

GENERAL SERVICES ADMINISTRATION

Federal Register Volume 82, Issue 1 (January 3, 2017)

Page Range122-122
FR Document2016-31786

GSA has issued a guidance for agencies and wholly-owned Government corporations, which provides a deadline to comply with recent regulatory changes that prohibit agencies from using prepayment auditors that have any affiliation with, or financial interest, in the transportation company (providing the transportation services) for which a prepayment audit is being conducted.

Federal Register, Volume 82 Issue 1 (Tuesday, January 3, 2017)
[Federal Register Volume 82, Number 1 (Tuesday, January 3, 2017)]
[Notices]
[Page 122]
From the Federal Register Online  [www.thefederalregister.org]
[FR Doc No: 2016-31786]


=======================================================================
-----------------------------------------------------------------------

GENERAL SERVICES ADMINISTRATION

[Notice-MA-2016-08; Docket No. 2016-0002; Sequence No. 31]


Federal Management Regulations; Transportation Prepayment Audit 
Requirements

AGENCY: Office of Government-wide Policy, General Services 
Administration (GSA).

ACTION: Notice of a bulletin.

-----------------------------------------------------------------------

SUMMARY: GSA has issued a guidance for agencies and wholly-owned 
Government corporations, which provides a deadline to comply with 
recent regulatory changes that prohibit agencies from using prepayment 
auditors that have any affiliation with, or financial interest, in the 
transportation company (providing the transportation services) for 
which a prepayment audit is being conducted.

DATES: Effective: January 3, 2017.

FOR FURTHER INFORMATION CONTACT: Mr. Ron Siegel, Program Analyst, 
Office of Government-wide Policy (MAF), Office of Asset and 
Transportation Management, General Services Administration at 202-357-
9540, or via email at [email protected]. Please cite FMR Bulletin D-
03.

SUPPLEMENTARY INFORMATION: FMR Bulletin D-03 provides guidance to all 
agencies (including the Department of Defense) and wholly-owned 
Government corporations as defined in 31 United States Code (U.S.C.) 
101, et seq. and 31 U.S.C. 9101(3). This bulletin provides agencies 
notice of a governmentwide policy revision for mandatory transportation 
prepayment audit plans, and provides a deadline for compliance with 
regulatory changes provided in FMR 102-118, Transportation Payment and 
Audit. FMR Bulletin D-03 and all other FMR bulletins are located at 
http://www.gsa.gov/fmrbulletins.

Kevin Kampschroer,
Associate Administrator (Acting), Office of Government-wide Policy, 
General Services Administration.
[FR Doc. 2016-31786 Filed 12-30-16; 8:45 am]
 BILLING CODE 6820-14-P



                                                122                            Federal Register / Vol. 82, No. 1 / Tuesday, January 3, 2017 / Notices

                                                further funding for clinical trials, and an             assist the company in establishing its                provides a deadline to comply with
                                                extensive amount of time to even reach                  manufacturing capabilities. Further, the              recent regulatory changes that prohibit
                                                the stage of applying to the FDA for                    Order requires that the parties transfer              agencies from using prepayment
                                                approval. The regulatory approval                       all confidential business information to              auditors that have any affiliation with,
                                                process itself can also be time-                        Terumo, as well as provide access to                  or financial interest, in the
                                                consuming as the FDA reviews the                        employees who possess or are able to                  transportation company (providing the
                                                volume of material and data a company                   identify such information. Terumo also                transportation services) for which a
                                                submits in support of its application.                  will have the right to interview and offer            prepayment audit is being conducted.
                                                The Consent Agreement                                   employment to employees associated                    DATES: Effective: January 3, 2017.
                                                                                                        with St. Jude’s vascular closure device               FOR FURTHER INFORMATION CONTACT: Mr.
                                                   The Consent Agreement remedies the                   business and Abbott’s steerable sheath                Ron Siegel, Program Analyst, Office of
                                                competitive concerns raised by Abbott’s                 business.                                             Government-wide Policy (MAF), Office
                                                proposed acquisition of St. Jude by                        The parties must accomplish the
                                                requiring that the parties divest to                                                                          of Asset and Transportation
                                                                                                        divestiture no later than forty-five days             Management, General Services
                                                Terumo all of the assets and resources                  after the consummation of the Proposed
                                                needed for it to become an independent,                                                                       Administration at 202–357–9540, or via
                                                                                                        Acquisition. If the Commission                        email at ron.siegel@gsa.gov. Please cite
                                                viable, and effective competitor in the                 determines that Terumo is not an
                                                U.S. markets for vascular closure                                                                             FMR Bulletin D–03.
                                                                                                        acceptable acquirer, or that the manner               SUPPLEMENTARY INFORMATION: FMR
                                                devices and steerable sheaths. It also                  of the divestiture is not acceptable, the
                                                requires Abbott to provide notice if it                                                                       Bulletin D–03 provides guidance to all
                                                                                                        Order requires the parties to unwind the              agencies (including the Department of
                                                intends to acquire ACT’s lesion-                        sale and accomplish the divestiture
                                                assessing ablation catheter assets.                                                                           Defense) and wholly-owned
                                                                                                        within 180 days of the date the Order                 Government corporations as defined in
                                                   Terumo possesses the industry                        becomes final to another Commission-
                                                experience and reputation necessary to                                                                        31 United States Code (U.S.C.) 101, et
                                                                                                        approved acquirer.                                    seq. and 31 U.S.C. 9101(3). This bulletin
                                                replace competition that would be lost                     To ensure compliance with the Order,
                                                in the U.S. markets for vascular closure                                                                      provides agencies notice of a
                                                                                                        the Commission has agreed to appoint
                                                devices and steerable sheaths. Terumo                                                                         governmentwide policy revision for
                                                                                                        an Interim Monitor to ensure that
                                                is headquartered in Tokyo, Japan. It has                                                                      mandatory transportation prepayment
                                                                                                        Abbott and St. Jude comply with all of
                                                been active in the U.S. medical device                                                                        audit plans, and provides a deadline for
                                                                                                        their obligations pursuant to the
                                                market for over thirty years and has a                                                                        compliance with regulatory changes
                                                                                                        Consent Agreement and to keep the
                                                U.S. subsidiary based in Somerset, New                                                                        provided in FMR 102–118,
                                                                                                        Commission informed about the status
                                                Jersey. Terumo offers a portfolio of                                                                          Transportation Payment and Audit.
                                                                                                        of the transfer of the rights and assets to
                                                products that are highly complementary                                                                        FMR Bulletin D–03 and all other FMR
                                                                                                        Terumo. Further, the Order allows the
                                                to the vascular closure and steerable                                                                         bulletins are located at http://
                                                                                                        Commission to appoint a Divestiture
                                                sheath products being acquired but does                                                                       www.gsa.gov/fmrbulletins.
                                                                                                        Trustee to accomplish the divestiture
                                                not sell any competing products.
                                                                                                        should the parties fail to comply with                Kevin Kampschroer,
                                                Through its Interventional Systems
                                                                                                        their divestiture obligations. Lastly, the            Associate Administrator (Acting), Office of
                                                business unit, Terumo manufactures
                                                                                                        Order terminates after ten years.                     Government-wide Policy, General Services
                                                and sells guidewires, catheters, and
                                                                                                           The purpose of this analysis is to                 Administration.
                                                sheaths, as well as other vascular access
                                                                                                        facilitate public comment on the                      [FR Doc. 2016–31786 Filed 12–30–16; 8:45 am]
                                                devices. As a result, it currently sells its
                                                                                                        proposed Consent Agreement, and it is                 BILLING CODE 6820–14–P
                                                products to many of the same customers
                                                                                                        not intended to constitute an official
                                                as Abbott and St. Jude. Terumo is thus
                                                                                                        interpretation of the proposed Order or
                                                well positioned to restore the benefits of
                                                                                                        to modify its terms in any way.                       OFFICE OF GOVERNMENT ETHICS
                                                competition that would be lost through
                                                the Proposed Acquisition.                                By direction of the Commission.
                                                   Pursuant to the Order, Terumo will                   April J. Tabor,                                       Request for Public Input on the
                                                receive all rights and assets related to St.                                                                  Application of the Criminal Conflict of
                                                                                                        Acting Secretary.
                                                Jude’s vascular closure device business                                                                       Interest Prohibition to Certain
                                                                                                        [FR Doc. 2016–31800 Filed 12–30–16; 8:45 am]
                                                and Abbott’s steerable sheath business,                                                                       Beneficial Interests in Discretionary
                                                                                                        BILLING CODE 6750–01–P
                                                including all of the intellectual property                                                                    Trusts.
                                                used in those businesses. In addition,                                                                        AGENCY:    Office of Government Ethics
                                                Terumo will take over part of the facility              GENERAL SERVICES                                      (OGE).
                                                in Caguas, Puerto Rico where St. Jude                   ADMINISTRATION                                              Notice of request for public
                                                                                                                                                              ACTION:
                                                currently manufactures most of its                                                                            comments.
                                                vascular closure device products. In                    [Notice–MA–2016–08; Docket No. 2016–
                                                order to ensure continuity of supply for                0002; Sequence No. 31]                                SUMMARY:    This notice and request seeks
                                                certain vascular closure devices and                                                                          input from members of the public with
                                                                                                        Federal Management Regulations;                       expertise in trust law concerning the
                                                components that are not currently
                                                                                                        Transportation Prepayment Audit                       following question: Are there any
                                                manufactured in the Puerto Rico
                                                                                                        Requirements                                          circumstances under which an eligible
                                                facility, the Order requires that St. Jude
                                                                                                                                                              income beneficiary of a discretionary
sradovich on DSK3GMQ082PROD with NOTICES




                                                supply Terumo with finished vascular                    AGENCY:  Office of Government-wide
                                                closure devices and components for up                   Policy, General Services Administration               trust might, in the absence of a vested
                                                to two years while Terumo transitions to                (GSA).                                                remainder interest, be able to compel
                                                independent manufacturing.                              ACTION: Notice of a bulletin.                         the trust to make a distribution or
                                                   To ensure that the divestiture is                                                                          payment? OGE will take into
                                                successful, the Order requires the                      SUMMARY:  GSA has issued a guidance for               consideration all relevant expert input
                                                parties to enter into a transitional                    agencies and wholly-owned                             submitted by the public within 60 days
                                                services agreement with Terumo to                       Government corporations, which                        of the date of this notice. To be


                                           VerDate Sep<11>2014   22:14 Dec 30, 2016   Jkt 241001   PO 00000   Frm 00041   Fmt 4703   Sfmt 4703   E:\FR\FM\03JAN1.SGM   03JAN1



Document Created: 2018-02-01 14:44:29
Document Modified: 2018-02-01 14:44:29
CategoryRegulatory Information
CollectionFederal Register
sudoc ClassAE 2.7:
GS 4.107:
AE 2.106:
PublisherOffice of the Federal Register, National Archives and Records Administration
SectionNotices
ActionNotice of a bulletin.
DatesEffective: January 3, 2017.
ContactMr. Ron Siegel, Program Analyst, Office of Government-wide Policy (MAF), Office of Asset and Transportation Management, General Services Administration at 202-357- 9540, or via email at [email protected] Please cite FMR Bulletin D- 03.
FR Citation82 FR 122 

2025 Federal Register | Disclaimer | Privacy Policy
USC | CFR | eCFR